scorecardresearch
Add as a preferred source on Google
Friday, February 6, 2026
TopicIndian pharmaceutical

Topic: Indian pharmaceutical

Chhindwara’s Coldrif deaths show India’s dangerous irony—pharmacy of the world, failing at home

Samridhi Tewari -
India’s pharmaceutical sector is valued at $50 billion. It has built its reputation on affordability and accessibility. The deaths in Chhindwara tell a different story.

Trump’s 100% pharma tariffs call for Indian firms to reimagine drug exports. Act quickly

Meenakashi Lekhi -
If the US is attempting to force localisation, India should respond aggressively with a proactive agenda. Here’s how.

On Camera

YourTurn

Opinion

Dear fans, don’t reduce WPL to players’ looks, skin colour. Focus on their cricket instead

Triya Gulati -
Despite milestones like WPL viewership and Smriti Mandhana’s record‑breaking century run, too many online voices treat athletes like fashion models.

Who are the real winners in the cloud services tax holiday

The idea of India rests on ‘traitors’ like Uttarakhand’s Mohammed Deepak

+TFP

Economy

Despite what Trump says, Russian oil imports to India can’t be wished away after US trade deal

Udit Bubna -
Market analysts say any shift in sourcing crude will be gradual, as refiners weigh freight costs, sanctions risks and deep discounts on Russian Urals.

Defence

Australian amphibian aircraft firm eyes Indian civil & military market, ties up with Apogee Aerospace

Debdutta Chakraborty -
Aligning with India's push to promote inter-coastal air connectivity, Apogee has ordered 15 seaplanes in a deal valued at Rs 3,500 crore.

National Interest

Swiss report should now close Op Sindoor debate. Knowing when to stop the fight is key too

Shekhar Gupta -
The key to fighting a war successfully, or even launching it, is a clear objective. That’s an entirely political call. It isn’t emotional or purely military.

Follow us

Copyright © 2025 Printline Media Pvt. Ltd. All rights reserved.